Dental Prophylaxis and Rheumatoid Arthritis
PREPARA II
Influence of Dental Prophylaxis on Disease Activity of Rheumatoid Arthritis
1 other identifier
interventional
70
1 country
1
Brief Summary
This study evaluates the influence of dental prophylaxis on disease activity of Rheumatoid Arthritis. In addition to standard antirheumatic therapy, recently the question has been raised whether or not there is a supplementary beneficial effect due to professional teeth cleaning. So far just a few studies pursued this question, indicating that prophylaxis by dental professionals can alleviate the symptoms of Rheumatoid Arthritis. To further evaluate this question, in our study half of the participants will receive dental prophylaxis at their first visit, after 2 weeks and 3 months, while the other half will receive professional teeth cleaning after 3 months only.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable rheumatoid-arthritis
Started Feb 2017
Typical duration for not_applicable rheumatoid-arthritis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 28, 2017
CompletedFirst Submitted
Initial submission to the registry
March 15, 2017
CompletedFirst Posted
Study publicly available on registry
March 22, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2020
CompletedMay 8, 2017
May 1, 2017
2.4 years
March 15, 2017
May 3, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Disease Activity Score 28 (DAS28)
The Disease Activity Score 28 (DAS28) combines single measures into an overall, continuous measure of Rheumatoid Arthritis disease activity. The DAS28 includes a 28 tender joint count, a 28 swollen joint count, acute phase reactant and a general health assessment on a visual analog scale.
baseline (T0) and three months (T2)
Secondary Outcomes (3)
Health Assessment Questionnaire (HAQ)
baseline (T0) and three months (T2)
Microbiome and Inflammatory Cytokine Profile
baseline (T0), three months (T2) and six months (T3)
Cumulative Steroid Dose
baseline (T0), three months (T2) and six months (T3)
Study Arms (2)
Test
EXPERIMENTALDental Prophylaxis at fist visit (T0), after 2 weeks (T1) and after 3 months (T2)
Control
OTHERWait \& Control Study Design: Dental Prophylaxis after 3 months (T2) only
Interventions
Prevention and treatment of periodontal diseases by cleaning of the teeth in the dental office using the procedures of dental scaling and dental polishing. The treatment includes plaque detection, removal of supra- and subgingival plaque and calculus, as well as motivation and demonstration for establishing a sufficient oral hygiene.
Eligibility Criteria
You may qualify if:
- Signed consent form
- Diagnosis of an active Rheumatoid Arthritis (DAS28 \> 3.2) by a rheumatologist
- Gingiva Bleeding Index (GBI) \> 10%, Plaque Control Record (PCR) \> 30% (indication for Dental Prophylaxis following the Heidelberg Therapeutic Scheme)
You may not qualify if:
- Generalized Severe Chronic Periodontitis
- Periodontal treatment within the last 6 months
- Dental Prophylaxis within the last 6 months
- Dental Prophylaxis being contraindicated due to dental or other reasons
- Antibiotic treatment within the last 3 months (excluding intake of antibiotic prophylaxis)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Heidelberg
Heidelberg, 69120, Germany
Related Publications (2)
Janssen KM, Vissink A, de Smit MJ, Westra J, Brouwer E. Lessons to be learned from periodontitis. Curr Opin Rheumatol. 2013 Mar;25(2):241-7. doi: 10.1097/BOR.0b013e32835d833d.
PMID: 23370377BACKGROUNDOrtiz P, Bissada NF, Palomo L, Han YW, Al-Zahrani MS, Panneerselvam A, Askari A. Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors. J Periodontol. 2009 Apr;80(4):535-40. doi: 10.1902/jop.2009.080447.
PMID: 19335072BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Diana Wolff, Prof. Dr. med. dent.
University Hospital Heidelberg
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Deputy Medical Director, Department of Conservative Dentistry
Study Record Dates
First Submitted
March 15, 2017
First Posted
March 22, 2017
Study Start
February 28, 2017
Primary Completion
August 1, 2019
Study Completion
February 1, 2020
Last Updated
May 8, 2017
Record last verified: 2017-05
Data Sharing
- IPD Sharing
- Will not share